Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30/09/2025 | 30/09/2024 |
|---|---|---|
| Revenue | 5M | 7M |
| Research and development | 38M | 42M |
| Selling, general and administrative | 14M | 11M |
| Operating expenses | 51M | 53M |
| Operating income | −51M | −53M |
| Pre-tax income | — | −43M |
| Net income | −46M | −43M |
| Earnings per share | −0.54 | −0.52 |
| Earnings per share, diluted | −0.54 | −0.52 |
| Weighted average shares | 85M | 83M |
| Weighted average shares, diluted | 85M | 83M |
| Metric | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 | 31/03/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 132M | 103M | 101M | 116M | 121M | 132M | 139M | 139M |
| Total assets | 133M | 104M | 102M |
| Metric | 30/09/2025 | 30/09/2024 |
|---|---|---|
| Operating cash flow | −39M | −31M |
| Share-based compensation | 12M | 9M |
| Financing cash flow | 9M | 12M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 117M |
| 124M |
| 136M |
| 142M |
| — |
| Total liabilities | 6M | 9M | 11M | 17M | 13M | 15M | 12M | — |
| Equity | 127M | 95M | 91M | 100M | 111M | 120M | 130M | 135M |
| Shares outstanding | 93M | 87M | 85M | 85M | 85M | 85M | 85M | — |
| Shares issued | 93M | 87M | 85M | 85M | 85M | 85M | 85M | — |